Winton Group’s Medpace MEDP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-479
| Closed | -$269K | – | 1283 |
|
|
2025
Q4 | $269K | Sell |
479
-545
| -53% | -$309K | 0.01% | 767 |
|
|
2025
Q3 | $527K | Sell |
1,024
-13,452
| -93% | -$5.87M | 0.02% | 567 |
|
|
2025
Q2 | $4.54M | Sell |
14,476
-5,478
| -27% | -$1.64M | 0.23% | 109 |
|
|
2025
Q1 | $6.08M | Buy |
19,954
+16,611
| +497% | +$5.59M | 0.37% | 56 |
|
|
2024
Q4 | $1.11M | Buy |
3,343
+1,006
| +43% | +$341K | 0.07% | 269 |
|
|
2024
Q3 | $780K | Buy |
2,337
+460
| +25% | +$175K | 0.05% | 364 |
|
|
2024
Q2 | $773K | Sell |
1,877
-526
| -22% | -$208K | 0.05% | 369 |
|
|
2024
Q1 | $971K | Buy |
2,403
+685
| +40% | +$241K | 0.07% | 277 |
|
|
2023
Q4 | $527K | Sell |
1,718
-140
| -8% | -$37.8K | 0.04% | 267 |
|
|
2023
Q3 | $450K | Buy |
1,858
+11
| +0.6% | +$2.81K | 0.04% | 283 |
|
|
2023
Q2 | $444K | Sell |
1,847
-4,905
| -73% | -$1.02M | 0.04% | 379 |
|
|
2023
Q1 | $1.27M | Sell |
6,752
-33,463
| -83% | -$6.92M | 0.08% | 356 |
|
|
2022
Q4 | $8.54M | Buy |
40,215
+38,216
| +1,912% | +$7.64M | 0.56% | 18 |
|
|
2022
Q3 | $314K | Sell |
1,999
-7,765
| -80% | -$1.24M | 0.02% | 780 |
|
|
2022
Q2 | $1.46M | Buy |
9,764
+1,531
| +19% | +$222K | 0.08% | 363 |
|
|
2022
Q1 | $1.35M | Buy |
8,233
+942
| +13% | +$155K | 0.07% | 370 |
|
|
2021
Q4 | $1.59M | Buy |
7,291
+268
| +4% | +$56.1K | 0.1% | 303 |
|
|
2021
Q3 | $1.33M | Sell |
7,023
-1,095
| -13% | -$200K | 0.07% | 362 |
|
|
2021
Q2 | $1.43M | Buy |
8,118
+478
| +6% | +$82.5K | 0.08% | 329 |
|
|
2021
Q1 | $1.25M | Sell |
7,640
-2,117
| -22% | -$324K | 0.07% | 341 |
|
|
2020
Q4 | $1.36M | Sell |
9,757
-18,653
| -66% | -$2.35M | 0.1% | 252 |
|
|
2020
Q3 | $3.17M | Sell |
28,410
-131
| -0.5% | -$15.1K | 0.1% | 303 |
|
|
2020
Q2 | $2.65M | Sell |
28,541
-42,010
| -60% | -$3.57M | 0.07% | 508 |
|
|
2020
Q1 | $5.18M | Sell |
70,551
-54,270
| -43% | -$4.71M | 0.14% | 239 |
|
|
2019
Q4 | $10.5M | Buy |
124,821
+88,783
| +246% | +$6.87M | 0.15% | 220 |
|
|
2019
Q3 | $3.03M | Buy |
36,038
+24,162
| +203% | +$1.83M | 0.04% | 424 |
|
|
2019
Q2 | $777K | Buy |
11,876
+6,101
| +106% | +$352K | 0.02% | 497 |
|
|
2019
Q1 | $341K | Buy |
+5,775
| New | +$345K | 0.01% | 750 |
|
Other funds holding MEDP
WA
Winton Group's MEDP Position: Q1 2026 in Review
Winton Group sold out of Medpace (MEDP) in Q1 2026, closing a stake of 479 shares — an estimated $269K sold.
Winton Group first reported a position in MEDP in Q1 2019 and held it in 28 quarters. The position peaked at $10.5M in Q4 2019. 733 funds tracked by Wall St. Rank hold MEDP as of Q1 2026.
- Winton Group reported no remaining Medpace position as of Q1 2026 after selling out during the quarter.
- Winton Group sold 479 Medpace shares in Q1 2026, an estimated $269K.
- Winton Group first reported a position in Medpace in Q1 2019 and held it in 28 quarters.
- Winton Group's Medpace position peaked at $10.5M in Q4 2019.
- 733 funds tracked by Wall St. Rank held Medpace as of Q1 2026.
Based on Winton Group's 13F filing for Q1 2026, filed 12 May 2026.